Skip To Content

Talis Biomedical Corporation Securities Litigation

1-877-331-0411

This official website is maintained by the Claims Administrator under the supervision of Lead Counsel in the action titled In re Talis Biomedical Securities Litigation, No. 22-cv-00105-SI (the “Action”) which is pending in the United States District Court for the Northern District of California (the “Court”).
*** Final Approval Granted ***

On March 21, 2025, the Court held a Final Approval Hearing and granted the Final Judgement Approving the Settlement as well as the Order Approving the Plan of Allocation and the Order Awarding Attorneys' Fees, Litigation Expenses, as found on the Court Documents section of this website. 

Notice

Please use the links below for the Notice documents related to this Action.

Settlement Documents:
Postcard Notice Long-Form Notice of Pendency and Proposed Settlement of Class Action Summary Notice of Class Settlement

Notice of Pendency Documents:
Postcard Notice Summary Notice of Pendency of Class Action Notice of Pendency of Class Action

Note: These documents are in PDF format. To view the
documents, you will need Adobe Acrobat Reader on your computer or other internet-enabled device.

Adobe Acrobat Reader